4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-24-000002
Chief Commercial Officer sold 2,902 shares at $22.32 ($64,773)
- Chief Commercial Officer acquired 8,475 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Milanova Tsveta Chief Commercial Officer | 2024-01-03 | Option exercise 10b5-1 | +8,475 | 12,306 | D | ||
| Milanova Tsveta Chief Commercial Officer | 2024-01-05 | Sale 10b5-1 | −2,902 | $22.32 | $64,773 | 9,404 | D |
| Derivatives | |||||||
| Milanova Tsveta Chief Commercial Officer | 2024-01-03 | Option exercise · Restricted stock units 10b5-1 | −8,475 | 16,951 | D | ||
| Open-market sales · 2,902 sh · avg $22.32 · $64,773 | |||||||
Loading xslF345X05/wk-form4_1704489026.xml…